KEAP1 Promotes Anti-tumor Immunity by Inhibiting PD-L1 Expression in NSCLC

Scientists discovered that KEAP1 serves as an E3 ligase to promote PD-L1 ubiquitination and degradation. They found that overexpression of KEAP1 suppressed tumor growth and promoted cytotoxic T cell activation in vivo.